Leviant Patent Portfolio Analysis

Thirteen million against a very old file

The round is $13M. Leviant was founded in 2021 and makes full-room and equipment cleaning devices for hospitals, offices and hotels. That is the surface: a hardware company with a sales problem, taking money to go and sell.

The filings tell a longer story. The earliest priority in the portfolio is 2005. That is sixteen years before the company was incorporated and roughly two decades before this cheque cleared. Whatever the round is funding, it is not the invention of the idea. The idea was written down while the market for it was still theoretical.

Seven solid ticks, three still thin

Ten families. Seven are granted, which means seven are enforceable today rather than someday. Three are published and pending, and the first of those could issue at any time. That is an unusually converted portfolio for a company this young, and it is the direct consequence of those old priority dates: time in prosecution has already been served.

Filings run through AU, JP, US and WO. Twenty-three inventors are named across the ten, but the spine is narrow. Michael Leviant appears on five. Luis F Romo appears on five. Audrey Mcnicholas on three. A wide bench of contributors, a very small set of people present at the centre of it.

Seven of ten are granted, which makes the portfolio an asset now rather than a promise.

Two bursts, a long gap, then silence

One family in 2005. One in 2006. Then three in 2010, the single largest year in the file. One in 2013, one in 2018, one in 2019. Two in 2022. The shape is not a startup ramp. It is a slow, deliberate accumulation stretched across seventeen years, with the heaviest concentration a decade before the company had a name.

The last public filing is dated 19 April 2022, fifty-two months before this round. Everything after that sits inside the shaded window, unpublished by rule. Four years of work is invisible from here. The titles that are visible point one direction: adaptive multivector illumination delivery, proportionality of distributed illumination, automated deposition of microfilms.

Samsung, Huawei, Qualcomm and a cleaning company

The claims cluster in two CPC areas: A61L, which is sterilisation and disinfection, and H04L, which is digital communication. The second one is why the neighbours look like this. Samsung has 356 families in the same groups over five years. Huawei 308. Qualcomm 276. Ericsson 88. Southeast University and Boeing 79 each. Leviant has ten.

On count alone that is not a contest. But count is the wrong measure in a crowded classification. What matters is where the specific claim boundaries fall and who got there first. A 2005 priority in a group the large filers entered later is a different kind of position than a 2022 filing beside them. Scope, not volume.

Two audiences reading the same file

The citation map splits cleanly. Xenex Disinfection Services cites the portfolio in 41 publications. Seoul Viosys in nine. Purplesun in nine. That is the disinfection world, reading Leviant as prior art in its own field, repeatedly and at volume.

Then there is Qualcomm, at thirteen, and P, at twelve. Those are not cleaning companies. They found the same documents from the communication side. A portfolio that reads as two things at once is rarely an accident of classification. It usually means the inventors framed the physical problem, delivering light precisely across a room, as a distribution and signalling problem, and wrote claims in that language.

Disinfection firms and a wireless firm are citing the same ten families.

What the go-to-market hiring actually signals

Five open roles. Four are go-to-market: a sales development representative, two area sales managers, a service operations manager. One is operations and finance. Nobody is being hired to file. That is the posture of a company whose invention phase is behind it and whose commercialisation phase is in front of it. The filings are the asset being sold, not the thing being built.

So the plain version. Leviant is not a 2021 idea that raised money. It is a seventeen-year filing record, mostly granted, written in two technical languages, that acquired a company and a sales team in 2021 and a balance sheet in [round year]. The $13M buys distribution for something that was already finished.